Top-tier pharma firms post growth despite fuel and power disruptions in Q1
The country's leading pharmaceutical companies managed to sustain revenue and profit growth in the July-September quarter of FY27 despite disruptions in gas and electricity supplies and rising fuel costs, although their expansion slowed to mostly …